| Serial Number | 79351089 |
| Word Mark | VALOTX |
| Filing Date | Thursday, April 21, 2022 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Tuesday, November 7, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 7, 2023 |
| Goods and Services | Contract manufacturing of pharmaceuticals, cells and gene therapy reagents, including custom manufacturing services of pharmaceuticals, cells and gene therapy reagents; custom manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, cellular immunotherapies, health care products and medical products; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; custom manufacturing of biological tissue, blood, and cells (including stem and progenitor cells, adult cells and immune cells); treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals and cellular immunotherapies |
| Goods and Services | Biopharmaceutical and pharmaceutical preparations for treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders; veterinary preparations; biological preparations for veterinary purposes for the treatment of tumors, cancers and infectious diseases; cultures of microorganisms for medical and veterinary use; biological preparations for medical purposes for the treatment of tumors, cancers and infectious diseases; drugs for medical purposes for the treatment of tumors, cancers and infectious diseases; diagnostic preparations for medical purposes; enzymes for medical purposes; biochemical medicines for the treatment of tumors, cancers and infectious diseases; vaccines; bioengineering pharmaceutical solutions for use in expanding cells for therapeutic use to patients with blood cancers and other diseases; biopharmaceuticals for the treatment of tumors, cancers and infectious diseases; cells for medical and clinical use, including, blood, stem cells, adult blood cells, immune cells, immunomodulatory cells, umbilical cord cells, umbilical cord blood, and placental tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; diagnostic preparations for medical purposes; Pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy; pharmaceutical preparations in the nature of cell solutions to enable cell expansion for therapeutic purposes; reagents for medical use for ex vivo cell processing in particular media suitable for the expansion of cells; Stem cells for medical or veterinary use; cells for medical purposes |
| Goods and Services | Chemical and biological reagents for scientific and research use; antioxidants for use in the manufacture of pharmaceuticals; Animal albumen as a raw material for industrial use; collagen for industrial purposes; antioxidants for use in manufacture; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; protein for use in manufacture; preparations of microorganisms, other than for medical and veterinary use; biological preparations for use in industry and science, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes |
| Goods and Services | Medical services, including regenerative treatment services; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno-oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; providing health and medical information about medical disorders and their diagnosis, prevention and treatment; cell and gene therapy medical treatment services |
| Goods and Services | Medical instruments and apparatus for the administration of gene and cell therapy, immunotherapy and immunomodulation and prophylaxis products; surgical and medical apparatus and instruments for gene and cell therapy, immunotherapy and immunomodulation and prophylaxis; veterinary apparatus and instruments, namely, for use in the treatment of tumors, cancers and infectious diseases; radiological apparatus for medical purposes; diagnostic apparatus for medical purposes, namely for use in the treatment of tumors, cancers and infectious diseases; apparatus for use in medical analysis, namely, for use in the treatment of tumors, cancers and infectious diseases; medical apparatus and instruments for use in the treatment of tumors, cancers and infectious diseases; surgical apparatus and instruments; breast pumps; apparatus, devices and articles for nursing infants, namely, nursing bottles; physiotherapy apparatus, namely, foam positioning pads and rollers for physical therapy use; galvanic therapeutic appliances for medical use; blood testing apparatus; medical devices for ex vivo cell processing |
| Goods and Services | Analysis of biological samples; biopharmaceutical and pharmaceutical development and research and evaluation services in the field of cell based therapeutics and gene therapy for the treatment of disease, injuries and disorders; biotechnology laboratory services; medical and scientific laboratory services; scientific and medical research consultation services and scientific and medical research and development services, including in the field of haematology, immunology, cancer research, developmental biology and life sciences, biotechnology, medical technology, cell culture, tissue engineering, genetic engineering, regenerative medicine, immunotherapy and immunomodulation; clinical research services in the field of in the field of haematology, immunology, cancer research, developmental biology and life sciences, biotechnology, medical technology, cell culture, tissue engineering, genetic engineering, regenerative medicine, immunotherapy and immunomodulation; medical and scientific research, namely, conducting clinical trials for others; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceutical preparations; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; cloud computing; chemical analysis; industrial design; conducting technical project studies; research and development of new products for others; material testing; biological research; scientific laboratory services; scientific research; bacteriological research |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Valo Therapeutics Oy |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | FI |
| Party Name | Valo Therapeutics Oy |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | FI |
| Event Date | Event Description |
| Thursday, September 29, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 30, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 4, 2022 | APPLICATION FILING RECEIPT MAILED |
| Sunday, October 23, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, February 9, 2023 | ASSIGNED TO EXAMINER |
| Friday, February 10, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, February 11, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, April 3, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, April 3, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, April 25, 2023 | REFUSAL PROCESSED BY IB |
| Sunday, October 1, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, October 1, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 2, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 4, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 18, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, November 6, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 7, 2023 | ABANDONMENT - AFTER PUBLICATION |
| Wednesday, October 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 18, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Thursday, November 2, 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Tuesday, November 7, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 7, 2023 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Friday, August 30, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, November 7, 2023 | ABANDONMENT - AFTER PUBLICATION |